Colorectal Cancer Trial, Recruiting NCT07422974 Sponsor: Osijek University Hospital Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT07422974
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older who have been diagnosed with colorectal cancer confirmed by a laboratory tissue test
  • People who are scheduled to have surgery for colorectal cancer, either using a keyhole (laparoscopic) approach or open surgery
  • People who are able to understand what the study involves and sign a written consent form
  • Both men and women are eligible
  • People whose overall health before surgery falls within a moderate risk category (known as ASA classification II or III — confirm with trial site if unsure which category applies)
  • People who received treatment before surgery (such as chemotherapy or radiation) will be placed in one group, and people who did not receive pre-surgery treatment will be placed in a separate comparison group

Who may not be able to join:

  • People under 18 years of age
  • People who are unconscious, confused, or otherwise unable to give informed consent
  • People who are unable to understand what the study involves
  • People who need emergency surgery
  • People who take corticosteroid medications (such as prednisone or cortisone) on a long-term basis

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Josipa Glavas Tahtler, MD, KBC Osijek, MEFOS

Phone: 00385959080119

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Osijek University Hospital
Registry
ClinicalTrials.gov
Start date
9 January 2026
Est. completion
31 December 2026

Where this trial is recruiting

🇭🇷 Croatia

Primary endpoints

Analysis of microvascular density; Degree of skin fibrosis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov